EC
HLF icon

Elequin Capital’s Herbalife HLF Stock Holding History

Elequin Capital’s Portfolio HLF Stock Details HLF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$750 Buy
57
+9
+19% +$124 ﹤0.01% 589
2026
Q1 		$707 Sell
48
-120
-71% -$1.96K ﹤0.01% 560
2025
Q4 		$2.17K Buy
+168
New +$1.78K ﹤0.01% 354
2025
Q3 		– Sell
-94
Closed -$810 – 247
2025
Q2 		$810 Buy
+94
New +$698 ﹤0.01% 343
2025
Q1 		– Sell
-6
Closed -$40 – 459
2024
Q4 		$40 Sell
6
-818
-99% -$6.08K ﹤0.01% 503
2024
Q3 		$5.92K Buy
+824
New +$7.59K ﹤0.01% 283
2024
Q2 		– Sell
-761
Closed -$7.65K – 259
2024
Q1 		$7.65K Buy
761
+722
+1,851% +$7.76K ﹤0.01% 124
2023
Q4 		$595 Sell
39
-15
-28% -$207 ﹤0.01% 319
2023
Q3 		$755 Sell
54
-1,139
-95% -$17.2K ﹤0.01% 335
2023
Q2 		$15.8K Buy
+1,193
New +$16.2K 0.01% 253
2023
Q1 		– Sell
-111
Closed -$1.65K – 418
2022
Q4 		$1.65K Buy
111
+66
+147% +$1.15K ﹤0.01% 586
2022
Q3 		$1K Sell
45
-21
-32% -$520 ﹤0.01% 516
2022
Q2 		$1K Sell
66
-6
-8% -$148 ﹤0.01% 356
2022
Q1 		$2K Buy
+72
New +$2.82K ﹤0.01% 259

Other funds holding HLF

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ROIC
Route One Investment Company San Francisco, California $2.49B AUM 10.92% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SP
Solel Partners Boston, Massachusetts $588M AUM 14.47% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Elequin Capital's HLF Position: Q2 2026 in Review

Elequin Capital increased its Herbalife (HLF) stake by 19% in Q2 2026, buying an estimated $124 and bringing the position to 57 shares worth $750. The position accounts for ﹤0.01% of the portfolio, ranked #589.

Elequin Capital first reported a position in HLF in Q1 2022 and has held it in 14 quarters since. The position peaked at $15.8K in Q2 2023. 235 funds tracked by Wall St. Rank hold HLF as of Q2 2026.

  • Elequin Capital held 57 shares of Herbalife worth $750 as of Q2 2026.
  • Elequin Capital bought 9 Herbalife shares in Q2 2026, an estimated $124.
  • Herbalife made up ﹤0.01% of Elequin Capital's portfolio in Q2 2026, its #589 holding.
  • Elequin Capital first reported a position in Herbalife in Q1 2022 and has held it in 14 quarters since.
  • Elequin Capital's Herbalife position peaked at $15.8K in Q2 2023.
  • 235 funds tracked by Wall St. Rank held Herbalife as of Q2 2026.

Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.